SAN DIEGO, July 21, 2014 /PRNewswire/ -- An International Trade Commission (ITC) ruling issued Friday held that, despite a redesign of its iCH CPAP device, Taiwanese device manufacturer APEX continues ...
ResMed’s shares were up as much as 2.5% in the trading session following the news release. The stock eventually closed at $51.29 yesterday, gaining around 2.2%. Per the ruling, the APEX XT and iCH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback